Goldman Sachs
ARMO

Goldman Sachs’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Goldman Sachs’s Portfolio ARMO Stock Details ARMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-67,026
Closed -$2.51M – 6256
2018
Q1 		$2.51M Buy
+67,026
New +$2.82M ﹤0.01% 3433

Goldman Sachs's ARMO Position: Q2 2018 in Review

Goldman Sachs sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 67,026 shares — an estimated $2.51M sold.

Goldman Sachs first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $2.51M in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

  • Goldman Sachs reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Goldman Sachs sold 67,026 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $2.51M.
  • Goldman Sachs first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • Goldman Sachs's ARMO BioSciences, Inc. Common Stock position peaked at $2.51M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Goldman Sachs's 13F filing for Q2 2018, filed 14 Aug 2018.